Transcranial Direct Current Stimulation for Migraine Attack
NCT ID: NCT01358279
Last Updated: 2016-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2009-01-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Direct Current Simulation in Chronic Migraine
NCT02817139
Does tDCS is Effective in the Prophylactic Treatment of Migraine
NCT01886274
tDCS for the Treatment of Migraine
NCT02562196
Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache
NCT01752439
Optimized tDCS for the Treatment of Migraine
NCT02562222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
migraine
transcranial direct current stimulation
A constant current of 2 mA intensity applied for 20 min over C3 or C4
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial direct current stimulation
A constant current of 2 mA intensity applied for 20 min over C3 or C4
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Migraine
* With or without aura
* The first attack of migraine was earlier than 50 years of age
* One to 8 moderate to severe migraine attacks per month in the 2 months preceding the screening
* Willing and able to give written informed consent
* Able to read, comprehend and complete the diary form
Exclusion Criteria
* Combined headache, including the tension type headache and medication overuse headache
* Pregnant, actively trying to become pregnant or breast-feeding women
* Uncontrolled and significant medical illness
* Vertebrobasilar or hemiplegic migraine according to the International Headache Society diagnostic criteria
* Having intracranial metal implants or a cardiac pacemaker
* A history of epilepsy or other organic brain disorders
* A history of psychological diseases
* Having changed medications for migraine within 1 month before giving us informed consent
* Drug abuser or alcoholics
17 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manho Kim
Manho Kim, MD, PhD Professor, Neurology Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-4615-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.